These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33014755)

  • 1. The Discovery of Clinically Applicable Biomarkers for Bipolar Disorder: A Review of Candidate and Proteomic Approaches.
    Muneer A
    Chonnam Med J; 2020 Sep; 56(3):166-179. PubMed ID: 33014755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic approaches to identify blood-based biomarkers for depression and bipolar disorders.
    Preece RL; Han SYS; Bahn S
    Expert Rev Proteomics; 2018 Apr; 15(4):325-340. PubMed ID: 29466886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review and Meta-Analysis on MS-Based Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Bipolar Disorder.
    Rodrigues JE; Martinho A; Santos V; Santa C; Madeira N; Martins MJ; Pato CN; Macedo A; Manadas B
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics strategies for bipolar disorder evaluation: From sample preparation to validation.
    de Jesus JR; Pessôa GS; Sussulini A; Martínez JLC; Arruda MAZ
    J Proteomics; 2016 Aug; 145():187-196. PubMed ID: 27113133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
    Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
    Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach.
    Niculescu AB; Levey DF; Phalen PL; Le-Niculescu H; Dainton HD; Jain N; Belanger E; James A; George S; Weber H; Graham DL; Schweitzer R; Ladd TB; Learman R; Niculescu EM; Vanipenta NP; Khan FN; Mullen J; Shankar G; Cook S; Humbert C; Ballew A; Yard M; Gelbart T; Shekhar A; Schork NJ; Kurian SM; Sandusky GE; Salomon DR
    Mol Psychiatry; 2015 Nov; 20(11):1266-85. PubMed ID: 26283638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers.
    Giusti L; Ciregia F; Mazzoni MR; Lucacchini A
    Expert Rev Proteomics; 2016 Oct; 13(10):941-950. PubMed ID: 27568681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review.
    MacDonald K; Krishnan A; Cervenka E; Hu G; Guadagno E; Trakadis Y
    Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):122-137. PubMed ID: 30411484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a blood-based diagnostic panel for bipolar disorder.
    Haenisch F; Cooper JD; Reif A; Kittel-Schneider S; Steiner J; Leweke FM; Rothermundt M; van Beveren NJM; Crespo-Facorro B; Niebuhr DW; Cowan DN; Weber NS; Yolken RH; Penninx BWJH; Bahn S
    Brain Behav Immun; 2016 Feb; 52():49-57. PubMed ID: 26441135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future.
    Comes AL; Papiol S; Mueller T; Geyer PE; Mann M; Schulze TG
    Transl Psychiatry; 2018 Aug; 8(1):160. PubMed ID: 30115926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders.
    Patel S
    Adv Protein Chem Struct Biol; 2014; 94():39-75. PubMed ID: 24629185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific alterations in plasma proteins during depressed, manic, and euthymic states of bipolar disorder.
    Song YR; Wu B; Yang YT; Chen J; Zhang LJ; Zhang ZW; Shi HY; Huang CL; Pan JX; Xie P
    Braz J Med Biol Res; 2015 Nov; 48(11):973-82. PubMed ID: 26375446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers for bipolar disorder: current status and challenges ahead.
    Teixeira AL; Colpo GD; Fries GR; Bauer IE; Selvaraj S
    Expert Rev Neurother; 2019 Jan; 19(1):67-81. PubMed ID: 30451546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
    Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
    J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological aspects and candidate biomarkers for psychotic bipolar disorder: A systematic review.
    Buoli M; Caldiroli A; Cumerlato Melter C; Serati M; de Nijs J; Altamura AC
    Psychiatry Clin Neurosci; 2016 Jun; 70(6):227-44. PubMed ID: 26969211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Search for plasma biomarkers in drug-free patients with bipolar disorder and schizophrenia using metabolome analysis.
    Kageyama Y; Kasahara T; Morishita H; Mataga N; Deguchi Y; Tani M; Kuroda K; Hattori K; Yoshida S; Inoue K; Kato T
    Psychiatry Clin Neurosci; 2017 Feb; 71(2):115-123. PubMed ID: 27676126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorder.
    McIntyre RS; Cha DS; Jerrell JM; Swardfager W; Kim RD; Costa LG; Baskaran A; Soczynska JK; Woldeyohannes HO; Mansur RB; Brietzke E; Powell AM; Gallaugher A; Kudlow P; Kaidanovich-Beilin O; Alsuwaidan M
    Bipolar Disord; 2014 Aug; 16(5):531-47. PubMed ID: 24330342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.